FDA Requires Black Box Warnings on Labeling for Botulinum Toxin Products.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 301, n. 22, p. 2316, doi. 10.1001/jama.2009.780
- By:
- Publication type:
- Article
Works matching DE "IPSEN Biopharm Ltd."
Results: 1
1